Aehr Test Systems (AEHR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Q1 fiscal 2025 revenue was $13.1 million, down 36% year-over-year from $20.6 million, primarily due to lower system shipments and weak electric vehicle demand.
Non-GAAP net income was $2.2 million ($0.07 per diluted share), down from $5.2 million ($0.18 per share) in Q1 FY24; GAAP net income was $0.7 million ($0.02 per share), down from $4.7 million.
Gross margin improved to 54.7% (non-GAAP) and 54.0% (GAAP), up from 48.7% and 48.4% year-over-year, driven by favorable product mix and increased WaferPak sales.
Completed the acquisition of InCAL Technology, broadening offerings in high-power AI, medical device testing, and packaged part reliability/burn-in test solutions.
Expansion into new markets including AI processors, gallium nitride (GaN) semiconductors, hard disk drive components, and flash memory is underway.
Financial highlights
Q1 revenue: $13.1 million; product revenue: $12.2 million; services revenue: $1.0 million.
WaferPak revenues were $12.1 million, representing 92% of total revenue, up from 55% in the prior year.
Operating income was $0.2 million (GAAP), down from $4.1 million; non-GAAP operating income was $1.65 million.
Cash, cash equivalents, and restricted cash totaled $40.8 million at quarter end, down from $51.1 million a year ago, after $10.6 million was used for the InCAL acquisition.
Bookings reached $16.8 million and backlog stood at $16.6 million as of August 30, 2024.
Outlook and guidance
Reaffirmed FY25 guidance: at least $70 million in revenue and pre-tax net profit of at least 10% of revenue.
Management expects momentum in silicon carbide and new market contributions in AI, GaN, and data storage.
Expect 85% of annual revenue from wafer-level burn-in and 15% from package part burn-in, with InCAL driving the latter.
Management expects existing cash resources and anticipated funds from operations to meet operating and capital needs for the next twelve months.
No material changes to risk factors or business outlook since the last annual report.
Latest events from Aehr Test Systems
- Record bookings and backlog drive projected 160%-200% FY27 revenue growth on AI demand.AEHR
Q4 202615 Jul 2026 - Record bookings and backlog contrast with a sharp Q3 revenue decline and rising cash reserves.AEHR
Q3 20268 Jul 2026 - Q3 revenue up 142% year-over-year, led by AI and new markets, with guidance withdrawn amid tariff uncertainty.AEHR
Q3 202530 Jun 2026 - Wafer-level burn-in adoption accelerates in AI and data center markets, driving growth and innovation.AEHR
46th Annual William Blair Growth Stock Conference2 Jun 2026 - Proprietary wafer-level test systems drive growth in AI, photonics, and power semiconductor markets.AEHR
Corporate presentation2 Jun 2026 - Wafer-level burn-in and automation drive growth in AI, memory, and photonics markets.AEHR
28th Annual Needham Growth Conference Virtual13 Apr 2026 - Advanced wafer-level test systems drive growth in AI, memory, and power semiconductor markets.AEHR
Corporate presentation23 Feb 2026 - AI and EV demand fuel growth as unique wafer-level testing secures market leadership.AEHR
17th Annual LD Micro Main Event Conference3 Feb 2026 - Record revenue and profit, strong 2025 outlook, and Incal acquisition drive growth in AI and GaN.AEHR
Q4 20243 Feb 2026